About Dr Cherie Ann Kruger
Dr Cherie Ann Kruger (PhD: Biomedical Technology) is an academic researcher who has made an exemplary international impact within the scientific fields of Photodiagnosis (PDD) and Photodynamic Therapy (PDT) cancer diagnosis, drug development and treatment. Furthermore, she has adapted these drug developments within the Complementary Medicine fields of application research in relation to anti-microbial resistance studies on various plant extracts.
She is currently employed full time within the UJ FHS Complementary Medicine Department as a full-time researcher and lecturer, as well as oversees their research facilities. Her research interest lies extensively within alternative complementary medicine drug development delivery systems for the effective combinative treatment of various cancers, as well as investigates their antimicrobial effectiveness in comparison to conventional medications.
Within her various research studies, she has graduated 1 doctorate, 6 masters’ (5 cum laude) and 6 honors students, as well as supervised 1 post-doctoral fellow to completion.
Currently she holds an impressive Scopus H-index of 16 (with 1438 citations), and this year was successfully awarded her NRF Y2 rating (2023), benchmarking the quality of her research and impact worldwide. Moreover, in 2019 she received the esteemed UJ Vice Chancellor’s Distinguished Award for Most Promising Researcher.
Over the years I she has been awarded the international grant CANSA (2019-2021) and various local grants, such as WRC (2014-2016), NRF Thuthuka (2019-2020), URC (2019-2022), NRF KIC (2017, 2019 & 2020) and NRF Unrated Researchers Funding (2022-2024), which have allowed her to pursue my research field of specialization. Furthermore, in 2017 she received the UJ Faculty of Health Sciences outstanding achievement award for her doctoral studies and in 2013 received the Faculty of Health Sciences Best Overall Performing Masters Student award.
Dr Kruger has presented her various research findings at 16 national and 8 international conferences. To date she published 22 peer reviewed scientific journal articles, 4 book chapters and 4 conference proceedings. Moreover, she is an internationally recognized guest editor for 3 journals and serves as an external reviewer for 31 journals. Additionally, she is an esteemed member of the European Association for Cancer Research and serves on the UJ HDC and REC committees as board member. Lastly, she lectures various undergraduate and postgraduate modules at the UJ, including Medical Microbiology and Biochemistry.